Skip to content

The Effectiveness of Extracorporeal Magnetotransduction therapy (EMTT) in children with arthritis: A Randomized control trial

The Effectiveness of Extracorporeal Magnetotransduction therapy (EMTT) in children with arthritis: A Randomized control trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250222008
Enrollment
32
Registered
2025-02-22
Start date
2024-11-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile idiopathic arthritis Extracorporeal Magnetotransduction therapy (EMTT) Juvenile idiopathic arthritis (JIA) children pain range of motion physical therapy circumference quality of life

Interventions

Extracorporeal Magneto transduction therapy (EMTT) 1/ week, for 1 month (total 4 session) + home physical therapy dose: depend on joint and patient weight/ size,The control group only get standard phy
Extracorporeal Magnetotransduction therapy, EMTT,home physical therapy

Sponsors

Research department, faculty of medicine Siriraj hospital, Mahidol university, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. age 6-18 years 2. patient who was diagnosed with Juvenile idiopathic arthritis (JIA) 3. Has not been treated with EMTT for the last 3 months 4. VAS score greater than or equal to 3 or pain when palpate and move 5. most pain in lower extremity 6. receive standard treatment form rheumatologist

Exclusion criteria

Exclusion criteria: 1. previous surgery in affected joint 2. infection, mass, tumor, or trauma in affected joint 3. not cooperate in EMTT

Design outcomes

Primary

MeasureTime frame
pain at 0, 1, 3 months VAS score

Secondary

MeasureTime frame
Range of motion at 0, 1, 3 months range of motion,joint circumference at 0, 1, 3 months joint circumference (neutral position, cm),muscle power at 0, 1, 3 months MRC muscle power scale,muscle atrophy at 0, 1, 3 months yes/no,quality of life at 0, 1, 3 months PedQL generic core scale

Countries

Thailand

Contacts

Public ContactRatcharin Kongkasuwan

Mahidol University

siratcharin@gmail.com0818049886

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026